Categories
Archives
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
Mar
17
Exploring the future of dermatology at AAD 2023
Mar
16
You Speak, We Listen: How Community Voices Drive Our Work in HS
Mar
15
Building a Community of Trust in Epilepsy & Rare Syndromes
Feb
17
Patient-First, Patient-Focused: Our Purpose and Promise
Jan
20
Employee Spotlight: Ian Crassweller – Leading and Evolving Through Change
Jan
18
Annals of the Rheumatic Diseases Publishes Results from Two Bimekizumab Phase 3 Studies in Axial Spondyloarthritis
Jan
06
UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review
Dec
23
UCB Announces FDA Acceptance of BLA Resubmission for Bimekizumab
Dec
13
Employee Spotlight: Leah VanderVeen and Her Time as a Court Appointed Special Advocate for Foster Children